Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male Subjects
Clinical trial NCT03435276 · COMPLETED
Trial details
- NCT number
- NCT03435276
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2018-06-13
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.